Doctors have warned that patients are being ‘set up for failure’ due to mismanagement of the rollout of Mounjaro ...

GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...